| Literature DB >> 32966913 |
Esma Bendjama1, Lotfi Loucif2, Widad Chelaghma3, Chahrazed Attal1, Fatma Zohra Bellakh1, Randa Benaldjia1, Imène Kahlat1, Amna Meddour1, Jean-Marc Rolain4.
Abstract
OBJECTIVES: The aim of this study was to screen for the presence of β-lactamase-producing Gram-negative bacteria (GNB) from Algerian currency collected from food vendors in Batna city, Algeria.Entities:
Keywords: Algeria; Carbapenemase; Enterobacter cloacae; Money; OXA-48
Mesh:
Substances:
Year: 2020 PMID: 32966913 PMCID: PMC7502170 DOI: 10.1016/j.jgar.2020.09.003
Source DB: PubMed Journal: J Glob Antimicrob Resist ISSN: 2213-7165 Impact factor: 4.035
Antibiotic susceptibility testing results and phenotypic and genetic characteristics of the isolates obtained in this study.
| Strain | Source | Species | Antibiotic susceptibility | Phenotypic and molecular characterisation | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMX | FOX | CTX | CAZ | FEP | ATM | AMC | TCC | ETP | IPM | TOB | GEN | AMK | CIP | DDST | MHT | MCNP test | ESBL gene | Carbapenemase gene | |||
| C1 | 5DA1 | R | S | R | R | S | I | S | S | S | S | R | I | S | R | + | N/D | N/D | CTX-M-27 | – | |
| C2 | 5DA1 | R | R | R | R | S | S | S | S | S | S | I | S | S | R | – | N/D | N/D | – | – | |
| C3 | 5DA1 | R | S | R | R | S | I | S | S | S | S | R | S | S | R | + | N/D | N/D | CTX-M-27 | – | |
| C4 | 5DA1 | R | R | R | S | S | S | R | R | R | S | S | S | S | S | – | + | + | – | OXA-48 | |
| C5 | 100DA2 | R | R | R | R | S | R | R | R | S | S | S | S | S | S | – | N/D | N/D | – | – | |
| C6 | 100DA2 | R | R | R | R | S | I | R | R | S | S | S | S | S | S | – | N/D | N/D | – | – | |
| C7 | 100DA2 | R | R | R | S | S | S | R | R | R | R | S | S | S | S | – | – | – | – | – | |
| C8 | 10DA3 | R | R | R | R | S | I | R | R | S | S | S | S | S | S | – | N/D | N/D | – | – | |
| C9 | 10DA3 | R | R | R | R | S | I | R | R | S | S | S | S | S | S | – | N/D | N/D | – | – | |
| C10 | 10DA4 | R | S | R | S | R | S | S | S | S | S | S | S | S | R | + | N/D | N/D | CTX-M-14 | – | |
| C 11 | 100DA5 | R | R | R | S | S | R | R | R | R | R | S | S | S | S | – | – | – | – | – | |
| C12 | 5DA6 | R | R | R | S | S | S | R | R | R | R | S | S | S | S | – | – | – | – | – | |
AMX, amoxicillin; FOX, cefoxitin; CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepime; ATM, aztreonam; AMC, amoxicillin/clavulanic acid; TCC, ticarcillin/clavulanic acid; ETP, ertapenem; IPM, imipenem; TOB, tobramycin; GEN, gentamicin; AMK, amikacin; CIP, ciprofloxacin; S, susceptible; I, intermediate; R, resistant; DDST, double-disk synergy test; MHT, modified Hodge test; MCNP, modified Carba NP; ESBL, extended-spectrum β-lactamase; DA, Algerian Dinar.
1, Pool 1 (containing 10 coins of 5 DA 1994 version); 2, Pool 2 (containing 10 coins of 100 DA); 3, Pool 3 (containing 10 coins of 10 DA 1994 version); 4, Pool 4 (containing 8 coins of 10 DA 1979 version); 5, Pool 5 (containing 10 coins of 100 DA); and 6, Pool 6 (containing 10 coins of 5 DA 1994 version).
–, negative; +, positive; N/D, not determined.